Equivalent price position
No other current listing with the same generic, strength, dosage form and compatible unit basis is available for comparison.
Price-position comparison uses current official listed prices normalized to compatible units. It is a price benchmark, not a measure of sales, demand, prescription volume or market share.
Product details
- Generic
- Deferasirox
- Therapeutic area
- Hematology & thrombosis
- Drug class
- Iron chelators
- ATC
- V03AC
- Strength
- 400 mg
- Dosage form
- Dispersible tablet
- Pack
- 30's
- Registration no.
- 068113
- Price record verified
- 2026-08-09
- Latest DRAP source check
- 2026-09-23 03:19
Manufacturer
CCL Pharmaceuticals (Pvt.) Limited
Explore this manufacturer's complete MedInfoBase portfolio, generics and current listed prices.
View company portfolio →Official price over time
No change in the official DRAP price is recorded for this pack (30's). Current price PKR 22,159.58, effective 23 Jul 2026.
Cite this price history
MedInfoBase. DASIROX 400 mg, 30's: official price history (source: DRAP PharmaPrice Index). https://medinfobase.com/brand/dasirox-400-mg-068113-30s-ccl-pharmaceuticals-pvt-ltd/ (accessed 23 September 2026).
Official price history
| Amount | Effective from | Verified | Source | Status |
|---|---|---|---|---|
| PKR 22,159.58 | 2026-07-23 | 2026-08-09 | DRAP PharmaPrice Index | Current |
Other listed brands
Cite this record
Medicine record · DRAP registration 068113Price and registration data on this page were observed on 9 August 2026. Records change over time, so please cite the observation date alongside the access date.
